Our goal is to improve clinical practice and disease monitoring in myeloproliferative neoplasms (MPNs). To achieve this, we focus on developing and implementing global standards and guidelines for diagnosis, treatment, and follow-up; supporting clinical trials and patient registries; promoting basic and translational research on MPN biology and pathogenesis; sharing scientific knowledge and best practices; educating healthcare professionals; and advocating for the rights and needs of people with MPNs. We operate as a collaborative and inclusive foundation, working with like-minded organizations and stakeholders, respecting regional diversity, applying evidence-based methods and innovative technologies, and acting with transparency and accountability.